FR2181804A1 - - Google Patents

Info

Publication number
FR2181804A1
FR2181804A1 FR7308349A FR7308349A FR2181804A1 FR 2181804 A1 FR2181804 A1 FR 2181804A1 FR 7308349 A FR7308349 A FR 7308349A FR 7308349 A FR7308349 A FR 7308349A FR 2181804 A1 FR2181804 A1 FR 2181804A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7308349A
Other versions
FR2181804B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2181804A1 publication Critical patent/FR2181804A1/fr
Application granted granted Critical
Publication of FR2181804B1 publication Critical patent/FR2181804B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7308349A 1972-03-08 1973-03-08 Expired FR2181804B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2211019A DE2211019C3 (de) 1972-03-08 1972-03-08 Geschmacksverbessernde Formulierungen oraler Penicilline

Publications (2)

Publication Number Publication Date
FR2181804A1 true FR2181804A1 (fr) 1973-12-07
FR2181804B1 FR2181804B1 (fr) 1976-10-22

Family

ID=5838215

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7308349A Expired FR2181804B1 (fr) 1972-03-08 1973-03-08

Country Status (14)

Country Link
US (1) US3872227A (fr)
JP (1) JPS4899317A (fr)
AT (1) AT326819B (fr)
BE (1) BE796446A (fr)
DE (1) DE2211019C3 (fr)
DK (1) DK132738C (fr)
ES (1) ES412387A1 (fr)
FR (1) FR2181804B1 (fr)
GB (1) GB1388358A (fr)
HU (1) HU167988B (fr)
IE (1) IE37378B1 (fr)
IL (1) IL41686A (fr)
NL (1) NL7303207A (fr)
ZA (1) ZA731589B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963239A1 (fr) * 2010-08-02 2012-02-03 Vetalis Formes galeniques effervescentes solides pour animaux

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
US5631038A (en) * 1990-06-01 1997-05-20 Bioresearch, Inc. Specific eatable taste modifiers
US5637618A (en) * 1990-06-01 1997-06-10 Bioresearch, Inc. Specific eatable taste modifiers
HUT68764A (en) * 1991-11-27 1995-07-28 Bioresearch Inc Eatable taste modifiers
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US7504376B2 (en) * 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
CH690817A5 (de) * 1996-09-03 2001-01-31 Flachsmann Ag Emil Verfahren zur Herstellung eines stabilen, homogenen, von Folgeprodukten freien oder nahezu freien Extraktes.
WO2000038536A2 (fr) 1998-12-23 2000-07-06 Mount Sinai School Of Medicine Of New York University Inhibiteurs de la reaction a la saveur amere
WO2003024428A1 (fr) * 2001-09-14 2003-03-27 Scolr, Inc. Forme posologique a administration orale de type comprime a liberation modifiee
JP2006052169A (ja) * 2004-08-12 2006-02-23 Wakoudou Kk ゾル状又はゲル状の服薬補助食品
US7455872B2 (en) * 2005-06-20 2008-11-25 Redpoint Bio Corporation Compositions and methods for producing a salty taste in foods or beverages
US7452563B2 (en) * 2005-06-20 2008-11-18 Redpoint Bio Corporation Compositions and methods for producing flavored seasonings that contain reduced quantities of common salt
CA2914468A1 (fr) 2013-07-18 2015-01-22 Sandoz Ag Melanges de poudres pour formulations de sirop sec antibiotique

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1477464A (fr) * 1964-12-03 1967-04-21 Bayer Ag Procédé pour diminuer les altérations de goût et d'odeur des pénicillines
FR2035119A1 (fr) * 1969-03-20 1970-12-18 Pfizer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1477464A (fr) * 1964-12-03 1967-04-21 Bayer Ag Procédé pour diminuer les altérations de goût et d'odeur des pénicillines
FR2035119A1 (fr) * 1969-03-20 1970-12-18 Pfizer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963239A1 (fr) * 2010-08-02 2012-02-03 Vetalis Formes galeniques effervescentes solides pour animaux
WO2012017363A1 (fr) * 2010-08-02 2012-02-09 Vetalis Sarl Formes galéniques effervescentes solides pour animaux

Also Published As

Publication number Publication date
ATA196073A (de) 1975-03-15
IE37378L (en) 1973-09-08
AT326819B (de) 1975-12-29
DE2211019C3 (de) 1980-08-28
US3872227A (en) 1975-03-18
FR2181804B1 (fr) 1976-10-22
DK132738C (da) 1976-07-05
HU167988B (fr) 1976-02-28
NL7303207A (fr) 1973-09-11
GB1388358A (en) 1975-03-26
IE37378B1 (en) 1977-07-06
DE2211019A1 (de) 1973-09-13
DE2211019B2 (de) 1979-12-20
ES412387A1 (es) 1976-01-16
AU5295473A (en) 1974-09-12
IL41686A0 (en) 1973-05-31
BE796446A (fr) 1973-09-10
DK132738B (da) 1976-02-02
IL41686A (en) 1976-10-31
ZA731589B (en) 1973-11-28
JPS4899317A (fr) 1973-12-15

Similar Documents

Publication Publication Date Title
FR2175126B1 (fr)
FR2181804B1 (fr)
JPS5246764B2 (fr)
FR2187615A1 (fr)
JPS4968650U (fr)
JPS5122486B2 (fr)
FR2168875B3 (fr)
JPS4947197U (fr)
CS155442B1 (fr)
FR2186466B1 (fr)
JPS5324308Y2 (fr)
CS159005B1 (fr)
JPS4948358U (fr)
CS152726B1 (fr)
CS156584B1 (fr)
CS155796B1 (fr)
CS156973B1 (fr)
CS157425B1 (fr)
CS157799B1 (fr)
CS157965B1 (fr)
CS159006B1 (fr)
CS160323B1 (fr)
JPS4992066U (fr)
JPS4985256U (fr)
JPS4913277U (fr)

Legal Events

Date Code Title Description
ST Notification of lapse